Elevated chronic inflammatory factors and myeloid-derived suppressor cells indicate poor prognosis in advanced melanoma patients.
about
The Role of Myeloid-Derived Suppressor Cells (MDSC) in Cancer ProgressionMiR-21: an environmental driver of malignant melanoma?Immunomodulatory effect of peritumorally administered interferon-beta on melanoma through tumor-associated macrophages.Chemokines in the melanoma metastasis biomarkers portrait.A comprehensive genome-wide analysis of melanoma Breslow thickness identifies interaction between CDC42 and SCIN genetic variantsIncreased regulatory T cells in acute lymphoblastic leukemia patients.Regulatory T cells in the immunotherapy of melanoma.The immunobiology of myeloid-derived suppressor cells in cancer.Increased regulatory T cells in acute lymphoblastic leukaemia patients.A clinical and biological perspective of human myeloid-derived suppressor cells in cancer.Circulating and disseminated tumour cells - mechanisms of immune surveillance and escape.Myeloid-derived suppressor cells and tumor escape from immune surveillance.CCR5 in recruitment and activation of myeloid-derived suppressor cells in melanoma.Immune biomarkers for chronic inflammation related complications in non-cancerous and cancerous diseases.Phenotypically resembling myeloid derived suppressor cells are increased in children with HIV and exposed/infected with Mycobacterium tuberculosis.Tadalafil has biologic activity in human melanoma. Results of a pilot trial with Tadalafil in patients with metastatic Melanoma (TaMe)Survival of metastatic melanoma patients after dendritic cell vaccination correlates with expression of leukocyte phosphatidylethanolamine-binding protein 1/Raf kinase inhibitory protein.Is immunity in cancer the key to improving clinical outcome?: Report on the International Symposium on Immunotherapy, The Royal Society, London, UK, 12-13 May 2017.Predictive immune markers in advanced melanoma patients treated with ipilimumab.Identification of inhibitors of myeloid-derived suppressor cells activity through phenotypic chemical screening.Cytotoxic antimelanoma drugs suppress the activation of M2 macrophages.Blockage of the NLRP3 inflammasome by MCC950 improves anti-tumor immune responses in head and neck squamous cell carcinoma.Immune biomarkers for prognosis and prediction of responses to immune checkpoint blockade in cutaneous melanoma.Repurposing drugs in oncology (ReDO)-selective PDE5 inhibitors as anti-cancer agents.Targeting Myeloid-Derived Suppressor Cells to Bypass Tumor-Induced Immunosuppression.Myeloid-Derived Suppressor Cells Hinder the Anti-Cancer Activity of Immune Checkpoint Inhibitors.Prognostic role of pretreatment circulating MDSCs in patients with solid malignancies: A meta-analysis of 40 studies
P2860
Q28076760-C9E0F24A-7E1D-4EB4-9FC8-BE631E60A3BBQ35786021-AB191C72-6809-4CB0-9214-99B631733EE3Q36107956-EE7D4E8E-B096-4939-BE76-7963F2C08AC8Q38403945-DEDA4AE6-ED59-4E8B-8311-F54679234403Q38445526-F2C18FD0-F799-4463-B6EA-56D653C6BC5DQ38539663-88C00F70-E251-40F9-B7FB-7D7EF02463E1Q38619815-0A63CC12-71AD-4059-9987-988B652784BFQ38649547-BBFF3CBE-5F47-4FFB-9DB1-4CC5284AD62CQ38747439-B9CB1F83-CD06-4731-96CC-A50C296ACBE9Q38847251-7BCF247F-359D-49DC-98E4-10B89F2FF226Q38958563-6B3587FD-E231-4996-880D-CAFF8001EE4AQ38992562-C15634DD-630E-499F-919D-D532F7C2206EQ39223523-94616298-852A-412B-B85F-01F29FD91BA9Q39412983-C5A797A7-071E-47E8-8C6A-2263D598F5B9Q40445818-E4744BEF-4B4E-4B19-B769-4923F1090F67Q41067892-E97C6ECD-0737-44C6-B67D-6F68293C4DEFQ41976096-FFC03899-D4B5-42C2-84BB-6ABAF2018AB2Q42336210-98E7E937-0BAA-4F09-848E-A851F1E2B781Q42427603-F8E36C4E-AB43-4332-BBCD-994F567FF765Q45160017-591005AF-9B78-4C81-B730-A796C9B08D88Q47916295-9BDFCC29-6373-400A-8BBE-6E1B1B8AFF6AQ48220238-44FF8216-E7A0-4F30-9584-051C42638565Q53068034-D9B91298-EC03-4AC0-A9C0-0750F724D90DQ55247585-F275CF3A-39D3-4E49-8D9E-DAB9AAC65041Q55265921-A749A06D-0C3A-403A-A711-7B91552CC321Q55295587-4E8FCD96-832B-4A27-AEF4-D8C93D142897Q57138311-61B30381-CFE5-461E-A345-DF903C13DF19
P2860
Elevated chronic inflammatory factors and myeloid-derived suppressor cells indicate poor prognosis in advanced melanoma patients.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Elevated chronic inflammatory ...... in advanced melanoma patients.
@en
type
label
Elevated chronic inflammatory ...... in advanced melanoma patients.
@en
prefLabel
Elevated chronic inflammatory ...... in advanced melanoma patients.
@en
P2093
P2860
P356
P1476
Elevated chronic inflammatory ...... in advanced melanoma patients.
@en
P2093
Huanhuan Jiang
Ludmila Umansky
Philipp Beckhove
Torsten J Schulze
Viktor Umansky
P2860
P304
P356
10.1002/IJC.29297
P577
2014-11-12T00:00:00Z